Bloodless CAR T-Cell Therapy

Interview With Lauren E. Bigham, PhD: The Psychosocial Needs of Patients Receiving CAR T-Cell Therapy, Part 2

Interview With Lauren E. Bigham, PhD: The Psychosocial Needs of Patients Receiving CAR T-Cell Therapy, Part 1

Welcome to the CAR T-Cell Therapy Resource Center! Here you’ll find current information, news items, highlights from the literature, case studies, and other resources that focus on CAR T-cell therapies and the advanced practitioner’s role in delivering high-quality care to our patients. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.


Sarah Jimenez, DNP, AGACNP-BC, AOCNP BMT/IEC Advanced Practice Provider Blood and Marrow Transplantation/Immune Effector Cell Therapy Program Augusta University/Georgia Cancer Center	Liza Rodriguez, DNP, E-MBA, APRN, AOCNP APP Manager Hematology/Blood and Marrow Transplant Program APP Council Chair Division of Hematologic Malignancies and Cellular Therapeutics The University of Kansas Cancer Center

Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy

BMT infonet: CAR T-Cell therapy

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

CAR T-Cell Therapy for Large B-Cell Lymphoma

ASH-ASTCT COVID-19 Vaccination for HCT and CAR T Cell Recipients: Frequently Asked Questions

Blood Advances

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Pediatric Blood & Cancer

Neuropsychological functioning in pediatric patients with leukemia or lymphoma treated with CAR T-cell therapy: A retrospective chart review

Cancer Cell

Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia

Journal of Clinical Oncology

Comparison of standard-of-care idecabtagene vicleucel and ciltacabtagene autoleucel in relapsed/refractory multiple myeloma

Oncogene

Preclinical application of a CD155 targeting chimeric antigen receptor T-cell therapy for digestive system cancers

Brain

Current state and perspectives of CAR T-cell therapy in central nervous system diseases

Blood

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML

Clinical Cancer Research

Phase I study of ROR1-specific CAR-T cells in advanced hematopoietic and epithelial malignancies

Leukemia

Anti-CD19 CAR-T cell therapy for acquired hemophilia A

Trends in Pharmacological Sciences

Boosting CAR-T cell therapy through vaccine synergy

CAR T-Cell Therapy Resource Center